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Abstract
Background: Epidural steroid injection is a non-operative minimally invasive procedure for pain relief in spinal canal stenosis.
However, there is no significant consensus regarding its efficacy.
Objectives: In this study, we aimed to evaluate the effectiveness of translaminar injection of triamcinolone in lumbar canal stenosis.
Methods: In a retrospective study, we included 111 patients with MRI-confirmed spinal canal stenosis who were irresponsive to 12
weeks of conservative treatment and underwent epidural injection of triamcinolone through the translaminar approach. Outcome
measures were routinely checked before the intervention and four weeks after the intervention, which included the Visual Analog
scale (VAS) for low back pain, VAS for lower-limb pain, and Oswestry Disability index (ODI).
Results: The study population included 32 (28.8%) males and 79 (71.2%) females with the mean age of 61 ± 13.4 years. The mean ODI,
VAS for low back pain, and VAS for lower-limb pain significantly improved at the final evaluation session (P < 0.001, P = 0.001, and
P < 0.001, respectively). The levels of improvement in ODI, VAS for low back pain, and VAS for lower-limb pain were considerably
more in patients with single-level involvement (P < 0.001, P = 0.04, and P < 0.001, respectively). Improvement of lower-limb VAS
was negatively correlated with age (r = -0.400, P < 0.001) and BMI (r = -0.525, P < 0.001). The ODI improvement was also negatively
correlated with BMI (r = -0.569, P < 0.001).
Conclusions: Epidural injection of triamcinolone through the translaminar approach could be regarded as an efficacious method
for the alleviation of pain and disability in patients with spinal canal stenosis.
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1. Background
Chronic pain is a global health problem. Many pieces
of research have focused on either developing new pain
management strategies or optimizing the available pain
management modalities (1-6). Back pain is a debilitat-
ing disorder with a variety of etiologies (2, 7-9). Spinal
canal stenosis refers to the narrowing of the spinal canal,
which results in the spinal cord and spinal nerve compres-
sion. The etiology of the disease is generally degenerative.
This condition can cause a variety of symptoms, includ-
ing pain, limb weakness, and numbness (10-12). In addi-
tion to the back and leg pain, patients with symptomatic
spinal canal stenosis are at high risk for developing other
serious complications due to their reduced activity (13). Ac-
quired spinal canal stenosis is quite common among elder-
lies, with a prevalence of 1.7% - 13.1% (14, 15). Therefore, de-
veloping new strategies for the treatment of this disorder
is of critical value.
Conservative treatment is considered the primary
choice of treatment in spinal canal stenosis. However, in
many cases, conservative therapy is not effective and there-
fore, surgical treatment is selected for the alleviation of
pain (16). Even so, the surgery is not always effective and
the symptoms may remain after the operation. In addi-
tion, in elderlies, anesthetic and postoperative complica-
tions should be taken into consideration, as they usually
have other medical problems (17). For these reasons, sur-
gical treatment of stenosis is associated with its own con-
cerns and long-term benefits of surgical management have
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been reported to be limited when compared to conserva-
tive management (18).
An epidural steroid injection is a non-operative min-
imally invasive procedure used for pain relief in spinal
canal stenosis. The main goal of this treatment is to re-
duce pain so that patients can resume their rehabilitation
programs. Although several investigations have been per-
formed for assessing the efficacy of this treatment in the
management of patients with spinal canal stenosis, there
is still no consensus on its effect size nor on the timing of
the trial, frequency, and duration of treatment (19). There-
fore, further studies are required to remove the available
uncertainties regarding the epidural steroid injection in
the treatment of spinal canal stenosis.
2. Objectives
In this study, we aimed to evaluate the efficacy of
translaminar injection of triamcinolone in 111 patients
with spinal canal stenosis who were irresponsive to 12
weeks of conservative management.
3. Methods
This retrospective study was confirmed by the
Ethics Committee of our institute under the code of
IR.BJRC.ER.1398.390. The participants provided written
consent to use their medical data for publication. Between
2017 and 2018, we recruited patients with radicular back
pain and apparent spinal canal stenosis in magnetic res-
onance imaging (MRI) who underwent epidural injection
of triamcinolone through translaminar approach and
evaluated them for the eligibility to include in this study.
The diagnosis was confirmed by two different spinal
surgeons. The indication for epidural injection was a non-
response to 12 months’ conservative treatment (activity
modification, nonsteroidal anti-inflammatory drugs, and
physical therapy), the age of > 18 years, and diagnosis
of severe spinal canal stenosis according to the criteria
for classifying lumbar spinal canal stenosis (CLSCS) (20).
This classification system is based on four parameters,
including Hufschmidt-grade, grading of MRI, self-paced
walking test, and stenosis ratio. Accordingly, the patients
were divided into four grades: grade 0 (CLSCS < 7), grade 1
(7 ≤ CLSCS < 10), grade 2 (10 ≤ CLSCS < 13), and grade 3 or
severe spinal canal stenosis (13 ≤ CLSCS ≤ 16.5).
Patients’ inclusion was not restricted by body mass in-
dex (BMI) and patients with any BMI were included. The
contraindications for epidural injection were current local
or systemic infection, local malignancy, local anesthetic or
steroid suspension allergy, adrenal suppression, American
Society of Anesthesiologists Classification (ASA) class 3 and
4, hemodynamic instability, hypersensitivity to agents, co-
agulopathy, diathesis, congestive heart failure, diabetes
mellitus, aortic stenosis, and increased intracranial pres-
sure. Patients with a disc herniation at the same level as
their stenosis, a history of spinal canal stenosis, and a his-
tory of spinal surgery for vertebral fracture were not se-
lected for this study. Finally, a total of 111 patients were iden-
tified as eligible for the study.
3.1. Injection Procedure
All the injections were performed by a single
fellowship-trained spine surgeon at the same center.
The patients were placed in the prone position and prep
and drape of the area were performed in a sterile fashion.
Then, the C-arm was set in a posteroanterior position.
After that, the midpoint of the intervertebral space at the
target level was identified. The skin was infiltrated with
a local anesthetic solution using a short 25-gauge needle
down to the lamina. A Tuohy needle 18 gauge was used for
epidural injection. The needle was introduced nearly 1 cm
paramedian at the level of the tip of the spinous process.
Then, the needle was angled slightly in the medial direc-
tion and advanced until contacting with the lamina. Once
the bony contact was made, the needle was redirected
with angle 45° with the parasagittal and 15° axial plane
medial and cephalad. Then, the C-arm was positioned
laterally and the needle was advanced with the loss of re-
sistance technique. The stylet of the needle was removed
afterward. A lubricated 5 ml syringe filled with saline
was attached and advanced under fluoroscopy. In case
a straight line image was visualized in the lateral vision,
the injection solution was released slowly, which included
Bupivacaine hydrochloride (Astrazeneca, France) 0.5% (3
mL) and triamcinolone acetonide (Hexal, Germany) 80 mg
(2 mL). After the recovery, the patients were discharged
from the hospital. No physical or manual therapy was
allowed during the study period.
3.2. OutcomeMeasures
The demographic characteristics of the patients, in-
cluding age, gender, and BMI, as well as the outcome mea-
sures, were extracted from the patients’ profile. The out-
come measures were routinely checked at our center be-
fore the intervention and four weeks after the interven-
tion, which included the Visual Analog scale (VAS) for lum-
bar pain, VAS for lower-limb pain, and Oswestry Disability
index (ODI). The VAS scores ranged from 0-10, where 0 rep-
resented no pain and 10 represented the extreme pain. The
ODI score ranged from 0 - 100, where 0 meant no disability
and 100 showed the maximum disability.
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3.3. Post-Injection Protocol
All patients received oral Gabapentin 100 mg (Razak
Darou, Iran) (100 mg/day) after the injection. They were
asked to rest and avoid strenuous activities on the day of
the epidural steroid injection. In case of severe pain, Di-
clofenac sodium 100 mg (Alborz Darou, Iran) (100 mg/day)
was administered as the rescue medication. Routinely, the
first follow-up of the patients was done four weeks after the
injection. However, they were asked to refer if any adverse
effect was noticed.
3.4. Statistical Analysis
We used SPSS version 16 for Windows (Chicago, Illi-
nois, USA) for the statistical evaluation of the data. De-
mographic data were presented as mean ± standard de-
viation or number and percentages. A comparison of
the outcome measures before and after the intervention
was made using a paired t-test or its nonparametric coun-
terpart (Wilcoxon signed-rank). The mean improvement
of outcome measures was compared between different
groups using an independent t test or its nonparametric
counterpart (Mann-Whitney U test). Pearson’s or Spear-
man’s correlation coefficient test was used for the evalua-
tion of potential correlations. A P value of less than 0.05
was considered significant.
4. Results
A total of 111 patients with radiologically confirmed
spinal canal stenosis were evaluated in this study. The
study population included 32 (28.8%) males and 79 (71.2%)
females. The mean age of the patients was 61 ± 13.4 years,
ranging from 32 to 84 years. Only was one level involved in
the majority of the patients (69 patients). The characteris-
tics of the patients are demonstrated in detail in Table 1.
The mean pre-treatment ODI was 57.2 ± 11 that im-
proved to 33.4 ± 15 after the intervention. This difference
was statistically significant (P < 0.001). The mean pre-
treatment VAS for lumbar pain was 6.4 ± 1.9, which im-
proved to 5.5 ± 1.6 after the intervention. This difference
was statistically significant, as well (P = 0.001). The mean
pre-treatment VAS for lower limb pain was 7.4 ± 1.5, which
improved to 4.2± 1.6 after the intervention. This difference
was statistically significant, too (P < 0.001).
The number of the involved levels was significantly
associated with the improvement of ODI, VAS for lumbar
pain, and VAS for lower extremity pain (P < 0.001, P = 0.04,
and P < 0.001, respectively). In this respect, the level of im-
provement was considerably more in patients with single-
level involvement (Table 2). No significant association was
Table 1. The Characteristics of the Patients with Spinal Stenosisa
Variable Patients (N = 111)








Body mass index, kg/m2 29.5 ± 2.8
Pre-treatment ODI 57.2 ± 11.7
Pre-treatment VAS for lumbar pain 6.9 ± 1.9
Pre-treatment VAS for lower limb pain 7.4 ± 1.5
Abbreviations: ODI, Oswestry Disability index; VAS, Visual Analogue scale.
aValues are expressed as mean ± SD or No. (%).
found between the sex of the patients and the improve-
ment of outcome measures.
The improvement of lower limb VAS was negatively
correlated with the age (r = -0.400, P < 0.001) and BMI (r = -
0.525, P < 0.001) of the patients. The ODI improvement was
also negatively correlated with the BMI of the patients (r =
-0.569, P < 0.001). No other significant correlations were
found between the outcome measures and the character-
istics of the patients.
No injection-associated complication was recorded in
the patients of this series until the date of the last follow-up
(four weeks after the intervention).
5. Discussion
In this study, we evaluated the effect of translaminar
injection of triamcinolone in 111 patients with spinal canal
stenosis who were irresponsive to 12 weeks of conservative
management. Based on the results of this investigation,
the translaminar injection of triamcinolone significantly
decreased the level of disability in the patients. In addition,
both lumbar and lower limb pain significantly improved
following the intervention. The improvement of outcome
measures was associated with the number of involved lev-
els, age, and BMI of the patients so that patients with single-
level involvement, lower age, and lower BMI revealed more
improvement.
The role of steroid injection in the alleviation of pain
and disability in spinal canal stenosis has been assessed in
many investigations. While some studies have shown the
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Table 2. Association of Outcome Measures Improvement with the Number of Involved Levelsa , b
Outcome Measure One-Level Involvement Two-Level Involvement Three-Level Involvement P Value
ODI improvement 27.2 ± 6.4 19.3 ± 4.7 14.7 ± 3.5 < 0.001
VAS for lumbar pain improvement 1.08 0.63 ± 0.7 0.88 ± 0.8 0.04
VAS for lower limb improvement 4 ± 1 1.8 ± 1.4 1.8 ± 1.3 < 0.001
Abbreviations: ODI, Oswestry Disability index; VAS, Visual Analogue scale.
aValues are expressed as mean ± SD or No. (%).
bP < 0.05 is considered significant.
positive effect of steroid injection on spinal canal steno-
sis, other investigations revealed no or minimal effect. For
this reason, several systematic reviews with diverse conclu-
sions have been published.
Manchikanti et al. (21) in 2012 reviewed the efficacy
of transforaminal epidural injection therapy for low-back
and lower extremity pain. The primary outcome measure
was short-term (up to six months) and long-term (more
than six months) pain relief. Secondary outcome measures
were an improvement in activity level, psychological sta-
tus, and reduction in opioid intake. A total of 25 studies
met the inclusion criteria and included in the study. Based
on their review, the results were fair for radicular pain sec-
ondary to spinal canal stenosis with local anesthetics and
steroids (21). By contrast to the results of this review, our re-
sults revealed the excellent improvement of pain and dis-
ability following the steroid injection.
Liu et al. (22) in 2015 aimed to investigate the effi-
cacy and safety of epidural steroid injections in the im-
provement of patients with lumbar spinal canal stenosis.
Ten articles (1,010 participants) were consistent with the
criteria of randomized controlled trials and included in
this investigation. Based on their results, there was mini-
mal evidence demonstrating the better efficacy of epidu-
ral steroid injections in comparison with lidocaine alone.
They concluded that the short-term and long-term benefits
of local anesthetics and steroids for the treatment of spinal
canal stenosis are minimal (22).
Manchikanti et al. (23) in 2015 aimed to systematically
review the efficacy of different approaches of anatomical
epidural injection (caudal, interlaminar, and transforam-
inal) in the treatment of spinal canal stenosis. The level
of evidence was II for long-term improvement in manag-
ing lumbar spinal canal stenosis for caudal and lumbar
interlaminar epidural injections. The level of evidence
was III for short-term improvement only by transforam-
inal epidural injections. The interlaminar injection ap-
peared to be more efficacious than the caudal injection,
and the caudal injection appeared to be more efficacious
than the transforaminal one (23). We evaluated the effect of
translaminar (interlaminar) steroid injection in patients
with spinal canal stenosis, which revealed to be efficacious,
at least for short-term implications.
A literature review revealed that several factors such as
the injection approach (19), type of anesthetic (24, 25), the
number of injections (26), and type and dose of steroids
could be different from study to study (27). Therefore, such
differences should be kept in mind when comparing the
results of different investigations.
Song et al. (24) aimed to compare the long-term effi-
cacy of translaminar epidural steroid injection in spinal
canal stenosis patients, with or without local anesthetics.
Similar to the present study, the steroid selection of choice
was triamcinolone. Based on their results, the Functional
Rate index (FRI) and VAS significantly improved in both
groups (24). The results of the present study were in accor-
dance with the results of a study by Song et al. (24) Such
similarity further supports the need for more homogene-
ity in future studies.
In spite of the potential advantages of epidural steroid
injections, the attributed risks to these injections should
also be considered. Recently, multiple reports have re-
ferred to the potential complications of epidural steroid
injections, including infections, spinal fluid leaks, urinary
retention, allergic reactions, headaches, stroke, blindness,
neurological deficits, seizures, etc. (28). Even so, none
of the above-mentioned complications was seen in the
present series.
The present study was not free of limitations. The main
limitation of the study was the absence of a control group
managed with an anesthetic alone. Therefore, we sug-
gest performing future investigations using such a control
group. In addition, the long-term follow-up of the patients
is proposed to evaluate the long-term effects of epidural in-
jection.
5.1. Conclusions
Epidural injection of triamcinolone through the
translaminar approach could be regarded as a safe and
efficacious method for the alleviation of pain and improve-
ment of disability in patients with spinal canal stenosis
who are not responsive to conservative management.
4 Anesth Pain Med. 2020; 10(1):e99764.
Sabbaghan S et al.
However, future controlled trials are required to support
the findings of the present study.
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